Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761130
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)Health Research Board, IrelandCompletedNot Applicable
NCT07761130Completed
Not Applicable
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke...Health Research Board, Ir...
NCT07759414
Chrono-Fasting in Overweight and Obese AdolescentsUniversity of ThessalyNot Yet RecruitingNot Applicable
NCT07759414Not Yet Recruiting
Not Applicable
Chrono-Fasting in Overweight and Obese AdolescentsUniversity of Thessaly
NCT07759440
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital Fracture RepairAlexandria UniversityRecruitingNot Applicable
NCT07759440Recruiting
Not Applicable
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital F...Alexandria University
NCT07759284
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People's HospitalNot Yet Recruiting
NCT07759284Not Yet Recruiting
—
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People'...
NCT07760766
Auricular Acupressure for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic ChemotherapyChina Medical University, ChinaNot Yet RecruitingNot Applicable
NCT07760766Not Yet Recruiting
Not Applicable
Auricular Acupressure for Prevention of Chemotherapy-Induced Nausea and Vomiting...China Medical University,...
NCT07761806
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams UniversityCompletedPhase 2
NCT07761806Completed
Phase 2
Comparsion of Effect of PRP,PDE5 Inhibitor in Treatment of Erectile DysfunctionAin Shams University
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07761208
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye UniversityNot Yet Recruiting
NCT07761208Not Yet Recruiting
—
Turkish Version of the Pictorial Pain Interference QuestionnaireIstinye University
NCT07759154
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional DysregulationOtsuka Pharmaceutical Development & Commercialization, Inc.Not Yet RecruitingPhase 3
NCT07759154Not Yet Recruiting
Phase 3
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hy...Otsuka Pharmaceutical Dev...
NCT07760987
Virtual Reality During Periodontal FrenectomyBilecik Seyh Edebali UniversitesiNot Yet RecruitingNot Applicable
NCT07760987Not Yet Recruiting
Not Applicable
Virtual Reality During Periodontal FrenectomyBilecik Seyh Edebali Univ...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07761065
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion in Skeletal Open Bite CasesAin Shams UniversityCompletedNot Applicable
NCT07761065Completed
Not Applicable
Efficiency of Microosteoperforation for Accelerating Posterior Segment Intrusion...Ain Shams University
NCT07761429
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)Shandong New Time Pharmaceutical Co., LTDRecruitingPhase 2
NCT07761429Recruiting
Phase 2
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Tr...Shandong New Time Pharmac...
NCT07760532
Comparing Facial Aging Between Identical Twins With 3D ImagingPonsky Facial Aesthetics And Plastic Surgery, LlcNot Yet Recruiting
NCT07760532Not Yet Recruiting
—
Comparing Facial Aging Between Identical Twins With 3D ImagingPonsky Facial Aesthetics...
NCT07759830
A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Menopausal Hot Flushes and Night Sweats.Queen's University, BelfastCompletedNot Applicable
NCT07759830Completed
Not Applicable
A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Meno...Queen's University, Belfa...
NCT07760350
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Minority Health and Health Disparities (NIMHD)Not Yet RecruitingNot Applicable
NCT07760350Not Yet Recruiting
Not Applicable
Assessing the Feasibility of the "Heart Care Pairs" InterventionNational Institute on Min...
NCT07761845
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn InjuriesAin Shams UniversityRecruiting
NCT07761845Recruiting
—
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of...Ain Shams University
NCT07759999
Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton TherapyUniversity of Wisconsin, MadisonRecruitingNot Applicable
NCT07759999Recruiting
Not Applicable
Clinical Evaluation of a Treatment Planning Software and Oncology Information Sy...University of Wisconsin,...
NCT07760857
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and Optimize MRI UtilizationChinese University of Hong KongNot Yet Recruiting
NCT07760857Not Yet Recruiting
—
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Ca...Chinese University of Hon...
Result Breakdown
Not yet recruiting12 (60%)
Completed4 (20%)
Recruiting4 (20%)
not_applicable10 (50%)
Not Specified6 (30%)
Phase 23 (15%)
Phase 31 (5%)